Sander F Garrelfs
Overview
Explore the profile of Sander F Garrelfs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
439
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Deesker L, Oubram L, Almardini R, Baum M, Bonilla-Felix M, Figueres L, et al.
Nephrol Dial Transplant
. 2025 Feb;
PMID: 39984743
Background And Hypothesis: Primary hyperoxaluria (PH) is a rare disorder with significant morbidity and mortality if left untreated. Given the rarity, global inequities in diagnostics and treatment are expected. Recently...
2.
Rosenberg N, Manders E, van den Berg S, Deesker L, Garrelfs S, de Visser S, et al.
Orphanet J Rare Dis
. 2024 Dec;
19(1):485.
PMID: 39716306
Background: The combination of high prices and uncertain effectiveness is a growing challenge in the field of orphan medicines, hampering health technology assessments. Hence, new methods for establishing price benchmarks...
3.
Wanders R, Groothoff J, Deesker L, Salido E, Garrelfs S
J Inherit Metab Dis
. 2024 Nov;
48(1):e12817.
PMID: 39582099
Glyoxylate is a toxic metabolite because of its rapid conversion into oxalate, as catalyzed by the ubiquitous enzyme lactate dehydrogenase. This requires the presence of efficient glyoxylate detoxification systems in...
4.
Deesker L, Karacoban H, Metry E, Garrelfs S, Bacchetta J, Boyer O, et al.
Kidney Int Rep
. 2024 Oct;
9(10):3006-3015.
PMID: 39430166
Introduction: Primary hyperoxaluria type 1 (PH1) is known for its variable clinical course, even within families. However, the extent of this heterogeneity has not been well-studied. We aimed to analyze...
5.
Garrelfs S, Chornyi S, Te Brinke H, Ruiter J, Groothoff J, Wanders R
J Inherit Metab Dis
. 2024 Jan;
47(2):280-288.
PMID: 38200664
Glyoxylate is a key metabolite generated from various precursor substrates in different subcellular compartments including mitochondria, peroxisomes, and the cytosol. The fact that glyoxylate is a good substrate for the...
6.
Metry E, Deesker L, Garrelfs S, Oosterveld M, Beekman K, Cornelissen E, et al.
Kidney Int
. 2023 Oct;
104(5):1038.
PMID: 37863627
No abstract available.
7.
Metry E, Garrelfs S, Deesker L, Acquaviva C, DAmbrosio V, Bacchetta J, et al.
Kidney Int Rep
. 2023 Oct;
8(10):2029-2042.
PMID: 37849991
Introduction: Primary hyperoxaluria type 1 (PH1) has a highly heterogeneous disease course. Apart from the c.508G>A (p.Gly170Arg) variant, which imparts a relatively favorable outcome, little is known about determinants of...
8.
Metry E, Deesker L, Garrelfs S, Oosterveld M, Beekman K, Cornelissen M, et al.
Kidney Int
. 2023 Jun;
104(1):203-204.
PMID: 37349052
No abstract available.
9.
Metry E, Garrelfs S, Peters-Sengers H, Vaz F, Bijlsma J, Neradova A, et al.
Nephrol Dial Transplant
. 2023 Mar;
38(7):1773-1775.
PMID: 36898675
No abstract available.
10.
Garrelfs S, Metry E, van Harskamp D, Vaz F, van den Akker C, Schierbeek H, et al.
Kidney Int
. 2023 Mar;
103(5):990-993.
PMID: 36871948
No abstract available.